• For Oncology Nurses: Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS Congress
    Jul 5 2025

    Dr Christopher Flowers and Dr Manali Kamdar summarize the clinical treatment landscape for patients with non-Hodgkin lymphoma, supported by clinical perspectives and management strategies from nurse practitioners Ms Robin Klebig and Ms Caitlin Murphy.

    NCPD information and select publications here.

    Show more Show less
    1 hr and 27 mins
  • For Oncology Nurses: Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress
    Jun 28 2025

    Dr Michael Mauro, Dr Neil Shah, and nurse practitioners Ms Ilene Galinsky and Dr Sara Tinsley-Vance discuss important nursing considerations in the modern treatment of chronic myeloid leukemia.

    NCPD information and select publications here.

    Show more Show less
    1 hr and 26 mins
  • IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies
    Jun 24 2025

    Dr Patrick Wen from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses the current and future management of IDH-mutant gliomas.

    CME information and select publications here.

    Show more Show less
    54 mins
  • Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
    Jun 18 2025

    Prof Meletios-Athanasios (Thanos) C Dimopoulos from the National and Kapodistrian University of Athens and Alexandra Hospital in Athens, Greece, and Dr Robert Z Orlowski from The University of Texas MD Anderson Cancer Center in Houston, Texas, provide their perspectives on relevant new clinical data in multiple myeloma and their application to disease treatment.

    CME information and select publications here.

    Show more Show less
    59 mins
  • Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances
    Jun 11 2025

    Professor Claire Harrison from the Guy’s and St Thomas’ NHS Foundation Trust in London, United Kingdom, and Dr John Mascarenas from The Tisch Cancer Institute in New York, New York, provide their perspectives on relevant new clinical data in myelofibrosis and discuss their application to treatment.

    CME information and select publications here.

    Show more Show less
    59 mins
  • Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
    Jun 5 2025

    Dr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major treatment advances over the past year and review relevant ongoing clinical trials for patients with non-Hodgkin lymphoma.

    CME information and select publications here.

    Show more Show less
    59 mins
  • Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
    Jun 2 2025

    Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis. 

    CME information and select publications here.

    Show more Show less
    48 mins
  • Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
    May 31 2025

    Clinical investigators discuss available data guiding the management of multiple myeloma. 

    CME information and select publications here.

    Show more Show less
    51 mins